Trial Profile
ERKENTNIS: Effentora in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2012
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms ERKENTNIS
- Sponsors Cephalon
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2012 Planned End Date changed from 1 Jun 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.